Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide has a half-life of roughly one week, meaning it takes approximately five weeks for the medicine to clear your system after your final injection. That long half-life is why a once-weekly dose keeps appetite suppression steady rather than peaking and dipping. It also means semaglutide keeps working — and keeps interacting with other medicines and hormones — for weeks after you stop. These are prescription-only medicines; a GPhC-registered prescriber assesses whether they're clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks: 'I forgot my injection) does that mean it's stopped working?' The honest answer is no, not immediately. Semaglutide's half-life sits at around seven days, and if you want a full breakdown of the timelines involved, our dedicated page on how long semaglutide stays in your body covers the pharmacokinetics in detail. Miss one weekly injection and you still have roughly half the previous week's circulating level in your system on day seven. Miss two in a row and that drops to around a quarter. By five weeks without a dose, most of the medicine has cleared.
That slow taper is by design. Semaglutide binds tightly to plasma albumin, which dramatically extends the time it spends in circulation compared with older GLP-1 medicines that needed daily dosing. The binding also explains why a single missed injection rarely causes an abrupt return of appetite, the decline is gradual. You can read more about how the medicine works over time on our Wegovy treatment page, which covers the full picture from first dose through to maintenance.
What this means practically: if you're late by a day or two, the clinical guidance is to take the dose as soon as you remember, provided the next scheduled dose is not within two days. Beyond that window, skip and resume your normal weekly schedule. Your prescriber and the Patient Information Leaflet are the definitive sources here; missed-dose decisions belong with them, not a general guide.
When people ask how long Wegovy stays in the body, they're often really asking one of two things: how quickly will side effects ease, or how soon can I start something else, including trying for a pregnancy? Both are fair questions with real clinical weight.
The five-week clearance estimate (five half-lives) is the standard pharmacokinetic benchmark. In practice, at that point semaglutide levels are below 3% of peak, low enough that most physiological effects, including slowed gastric emptying, have largely resolved. The MHRA advises a wash-out period before trying to conceive; speak to your prescriber or GP for the specific timing applicable to your situation.
Weight trajectory after stopping is a separate matter. The plateau and regain pattern documented in clinical literature reflects biology, not failure. Semaglutide treats a chronic condition; when the medicine clears, the underlying appetite signals that drove weight gain tend to return, gradually at first, then more noticeably. The STEP 1 trial, published in the New England Journal of Medicine, found that participants regained a substantial portion of lost weight within a year of stopping 2.4mg semaglutide. That evidence is why questions about duration of treatment deserve a careful clinical conversation, our page on how long you can stay on semaglutide goes into that in more detail.
The slow clearance of semaglutide has implications beyond appetite. Gastric emptying remains slower than normal while the medicine is active (and for a period after stopping) which affects how quickly other oral medicines reach peak concentration. This matters most around surgical procedures. Anaesthetic teams need to know you take or recently took semaglutide, because aspiration risk from a fuller stomach is a genuine concern under sedation. NHS England's guidance on weight-management medicines is clear: inform every healthcare professional involved in your care, including the anaesthetist, before any procedure.
For people switching from the injection to oral semaglutide, or moving between doses, the lingering half-life is a clinical consideration your prescriber factors in. It's one reason how quickly Wegovy takes effect is a different question from how long it lingers, the onset of appetite suppression and the clearance curve run on different timescales.
If side effects are your concern after stopping, the GI symptoms (nausea, constipation, indigestion) typically ease within one to two weeks of the last dose for most people, in line with the falling plasma levels. Severe or persistent symptoms after stopping should be discussed with a GP or reported via the MHRA Yellow Card scheme, which exists specifically for suspected medicine side effects.
Understanding the half-life also shapes what restarting looks like. If you've had a break of four weeks or more, a prescriber will typically restart at the beginning of the titration schedule rather than returning to the dose you left off at. The body's tolerance to GI side effects built up during the initial escalation is not retained indefinitely once the medicine clears. That's a clinical safety measure, not a setback.
People wondering about the cost of ongoing treatment can find a clear breakdown of what Wegovy costs privately through nume (including what's covered in a single transparent price) or explore the broader weight-loss treatment options we offer. If you're ready to discuss whether semaglutide suits your situation, start your free consultation and a GPhC-registered prescriber will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.